164 related articles for article (PubMed ID: 35892885)
61. Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry.
Davis JN; Medbery C; Sharma S; Perry D; Pablo J; D'Ambrosio DJ; McKellar H; Kimsey FC; Chomiak PN; Mahadevan A
J Radiat Oncol; 2015; 4(1):55-63. PubMed ID: 25774243
[TBL] [Abstract][Full Text] [Related]
62. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
[TBL] [Abstract][Full Text] [Related]
63. Fostering efficacy of anti-PD-1-treatment: Nivolumab plus radiotherapy in advanced non-small cell lung cancer - study protocol of the FORCE trial.
Bozorgmehr F; Hommertgen A; Krisam J; Lasitschka F; Kuon J; Maenz M; Huber PE; König L; Kieser M; Debus J; Thomas M; Rieken S
BMC Cancer; 2019 Nov; 19(1):1074. PubMed ID: 31703637
[TBL] [Abstract][Full Text] [Related]
64. Outcomes and prognostic factors for recurrence after high-dose proton beam therapy for centrally and peripherally located stage I non--small-cell lung cancer.
Kanemoto A; Okumura T; Ishikawa H; Mizumoto M; Oshiro Y; Kurishima K; Homma S; Hashimoto T; Ohkawa A; Numajiri H; Ohno T; Moritake T; Tsuboi K; Sakae T; Sakurai H
Clin Lung Cancer; 2014 Mar; 15(2):e7-12. PubMed ID: 24365049
[TBL] [Abstract][Full Text] [Related]
65. [Dose distributions of proton beam therapy for hepatocellular carcinoma: a comparative study of treatment planning with 3D-conformal radiation therapy or intensity-modulated radiation therapy].
Li JM; Yu JM; Liu SW; Chen Q; Mu XK; Jiang QA; Zhao MH; Zhang JG
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(45):3201-6. PubMed ID: 20193534
[TBL] [Abstract][Full Text] [Related]
66. Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
Jhaveri J; Cheng E; Tian S; Buchwald Z; Chowdhary M; Liu Y; Gillespie TW; Olson JJ; Diaz AZ; Voloschin A; Eaton BR; Crocker IR; McDonald MW; Curran WJ; Patel KR
Front Oncol; 2018; 8():440. PubMed ID: 30547008
[No Abstract] [Full Text] [Related]
67. Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry.
Jongen A; Charlier F; Baker K; Chang J; Hartsell W; Laramore G; Mohindra P; Moretti L; Redman M; Rosen L; Tsai H; Van Gestel D; Vargas C; Rengan R
Adv Radiat Oncol; 2022; 7(1):100767. PubMed ID: 35071826
[TBL] [Abstract][Full Text] [Related]
68. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
[TBL] [Abstract][Full Text] [Related]
69. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity.
Bishop AJ; Greenfield B; Mahajan A; Paulino AC; Okcu MF; Allen PK; Chintagumpala M; Kahalley LS; McAleer MF; McGovern SL; Whitehead WE; Grosshans DR
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):354-61. PubMed ID: 25052561
[TBL] [Abstract][Full Text] [Related]
70. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
[TBL] [Abstract][Full Text] [Related]
71. Effect of Radiation Doses to the Heart on Survival for Stereotactic Ablative Radiotherapy for Early-stage Non-Small-cell Lung Cancer: An Artificial Neural Network Approach.
Chan ST; Ruan D; Shaverdian N; Raghavan G; Cao M; Lee P
Clin Lung Cancer; 2020 Mar; 21(2):136-144.e1. PubMed ID: 31932217
[TBL] [Abstract][Full Text] [Related]
72. Significant Correlation Between Overall Survival and Mean Lung Dose in Lung Stereotactic Body Radiation Therapy (SBRT).
Dupic G; Biau J; Molnar I; Chassin V; Dedieu V; Lapeyre M; Bellière-Calandry A
Front Oncol; 2020; 10():1577. PubMed ID: 32850462
[TBL] [Abstract][Full Text] [Related]
73. Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer.
Rossi G; Simoni N; Paiella S; Rossi R; Venezia M; Micera R; Malleo G; Salvia R; Giuliani T; Di Gioia A; Auriemma A; Milella M; Guariglia S; Cavedon C; Bassi C; Mazzarotto R
Front Oncol; 2021; 11():662205. PubMed ID: 33959509
[TBL] [Abstract][Full Text] [Related]
74. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
[TBL] [Abstract][Full Text] [Related]
75. Increased biologically effective dose (BED) to the primary tumor is associated with improved survival in patients with oligometastatic NSCLC.
Farooqi A; Ludmir EB; Mitchell KG; Antonoff MB; Tang C; Lee P; Chang J; Elamin Y; Gomez DR; Gandhi SJ
Radiother Oncol; 2021 Oct; 163():114-118. PubMed ID: 34419505
[TBL] [Abstract][Full Text] [Related]
76. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for Stage 1 and node negative Stage 2 non-small cell lung cancer (NSCLC).
Lucas JT; Kuremsky JG; Soike M; Hinson WW; Kearns WT; Hampton CJ; Blackstock AW; Urbanic J
Lung Cancer; 2014 Jul; 85(1):59-65. PubMed ID: 24813936
[TBL] [Abstract][Full Text] [Related]
77. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
[TBL] [Abstract][Full Text] [Related]
78. Hypofractionated three-dimensional conformal radiotherapy for medically inoperable early stage non-small-cell lung cancer.
Lee JH; Wu HG; Kim HJ; Park CI; Lee SH; Kim DW; Heo DS
Radiat Oncol J; 2013 Mar; 31(1):18-24. PubMed ID: 23620865
[TBL] [Abstract][Full Text] [Related]
79. [Dosimetric comparing between protons beam and photons beam
for lung cancer radiotherapy: a meta-analysis].
Tian G; Li N; Li G
Zhongguo Fei Ai Za Zhi; 2013 May; 16(5):252-60. PubMed ID: 23676982
[TBL] [Abstract][Full Text] [Related]
80. Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer.
Wang C; Nakayama H; Sugahara S; Sakae T; Tokuuye K
Strahlenther Onkol; 2009 Apr; 185(4):231-4. PubMed ID: 19370425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
